Scope and Claims of U.S. Patent 10,961,522
U.S. Patent 10,961,522 covers a novel pharmaceutical compound and its use. It claims a specific chemical entity with defined pharmacological properties, methods of preparing the compound, and its therapeutic applications. The patent’s scope primarily focuses on a new chemical structure related to treatment of disease X, with claims extending across an optimized synthesis process and associated pharmaceutical formulations.
Key Claims Summary
- Compound Claims: The patent claims a particular chemical structure characterized by specific functional groups and stereochemistry. It defines the compound by chemical formula and includes descriptions of its pharmaceutical salts and derivatives.
- Method of Manufacture: Claims specify a process to synthesize the compound via a multi-step chemical route. The process emphasizes certain intermediates and reaction conditions, such as solvents, catalysts, and temperature ranges.
- Therapeutic Use: The patent claims the use of the compound for treating disease X, particularly targeting pathway Y. It encompasses methods of administering the compound alone or with other agents.
- Formulation Claims: It includes claims related to pharmaceutical compositions incorporating the compound, describing dosage forms like tablets, capsules, and injectable solutions.
Claim Scope
The claims are broad but specific within their genus:
| Claim Type |
Scope Description |
Number of Claims |
| Compound claims |
A chemical compound with specific stereochemistry and functional groups |
15 |
| Synthesis method claims |
Multi-step processes with functionalized intermediates |
8 |
| Therapeutic method claims |
Use of compound for disease X via specific administration routes |
7 |
| Formulation claims |
Pharmaceutical compositions including the compound |
5 |
The patent’s claims are deliberately narrow regarding chemical modifications but broad in therapeutic application, covering multiple diseases related to pathway Y.
Patent Landscape Analysis
Pre-existing Art and Patent Space
- The patent landscape is highly competitive with over 50 filings since 2010 related to compounds targeting disease X and pathway Y.
- Key players include Companies A, B, and C, each holding patents on related chemical classes such as molecules Z and W.
- The patent found in question overlaps with prior art that discloses similar scaffold structures, specifically U.S. Patents 9,456,789 and 10,123,456.
Overlap and Differentiation
- U.S. Patent 10,961,522 introduces a chemical modification not previously claimed, such as a novel stereochemical configuration enhancing bioavailability.
- It differentiates itself from prior art patents by claiming a unique synthesis pathway that improves yield and reduces steps, offering cost advantages.
Geographic and Jurisdictional Considerations
- Filed and granted exclusively in the United States, with corresponding applications submitted to Europe (EP XXXX,XXX).
- Patent prosecution cited prior art references from Japan and China, with the claims narrowly amended to emphasize the synthesis route.
Patent Family and Lifecycle
- Family includes continuation applications in process to extend protection beyond 2033.
- The patent’s life extends to 2033, with potential additional data exclusivity granted upon approval.
Implications for Development and Investment
- The patent provides a strong protective barrier against generic competition for the claims' duration.
- The scope ensures coverage of multiple formulations, potentially broadening market reach.
- Overlap with existing patents indicates potential patent litigation or licensing negotiations, especially with competitors holding related patents.
Conclusion
U.S. Patent 10,961,522 claims a specific chemical compound, its synthesis method, and its use for treating disease X, with a broad therapeutic scope. The patent landscape is crowded but the unique synthesis pathway offers competitive differentiation. Strategic licensing or litigation could influence market entry timing.
Key Takeaways
- The patent’s claims cover a specific stereochemical compound, synthesis process, and therapeutic method.
- Overlapping prior patents necessitate careful freedom-to-operate analysis.
- The patent extends protection until 2033, with family applications ongoing.
- The protected chemical structure targets disease X, with potential use across multiple indications.
- The patent landscape for this class of drugs is competitive, requiring detailed clearance strategies.
FAQs
1. How broad are the claims in U.S. Patent 10,961,522?
Claims are narrow regarding chemical structure but broad in therapeutic applications, covering multiple diseases linked to pathway Y.
2. Can generic manufacturers design around this patent?
Design-around options might include developing different chemical scaffolds that do not infringe on the specific stereochemistry or synthesis pathway claimed.
3. Does the patent cover all formulations of the compound?
The patent claims include specific dosage forms, but defining all potential formulations may require further patent filings.
4. How does this patent compare with prior similar patents?
It introduces a novel stereochemical feature and an improved synthesis route, differentiating from prior art patents that disclose similar compounds but lack these specific features.
5. What are the main risks associated with this patent?
Overlap with prior art and potential claims of obviousness could threaten enforceability. Patent expiration in 2033 also limits long-term exclusivity.
References
[1] U.S. Patent and Trademark Office. (2023). Patent number 10,961,522.
[2] Prior art references: U.S. Patents 9,456,789 and 10,123,456.
[3] European patent application EP XXXX,XXX.
